#Metabolism 

- 10% of [[Diabetes|diabetes]] cases
- Juvenile diabetes or insulin-dependent diabetes mellitus (IDDM)
- Body does not produce enough [[Insulin|insulin]]
## Causes
- Autoimmune disorder
- Pancreatic [[Pancreas#$ beta$-Cells (70%)|beta cell]] destruction
	- Mediated primarily by *cytotoxic T-cells*
	- B cells and antigen-presenting cells also play role
### Genetic Disposition
- Strong **genetic** predisposition
![[Diabetes-20240709011220741.png]]
### Environmental Risk Factors
- Type 1 diabetes has risen dramatically over past 30 years
- Could trigger islet autoimmunity
	- Primarily in genetically predisposed people
![[Diabetes-20240709011457839.png]]
## Pathogenesis ![[Diabetes-20240709011633949.png]]
- $\alpha$ cells are spared in type 1 diabetes
	- Secrete increased levels of [[Glucagon|glucagon]]
		- Exacerbates hyperglycaemia
![[Diabetes-20240709012237521.png]]
## Treatment
![[Type 1 Diabetes-20240709121045782.png]]
- Insulin injections or insulin pump
	- *Long* & *short* acting to mimic *basal* & *post-meal* insulin levels
- Blood glucose testing
	- Monitor glucose levels & adjust insulin levels
### Hypoglycaemia
- Life-threatening condition
- Occurs when blood glucose level **<4 mmol/L**
	- Normal: 5-10 mmol/L
- Can result from:
	- Administering too much insulin
	- Missing a meal
	- Unplanned physical activity
![[Type 1 Diabetes-20240709121350812.png|603]]
#### Treatment
- Conscious → Sugar (e.g., chocolate or orange juice)
- Unconscious → Glucagon or IV glucose (paramedic)
### New Approaches
- TrialNet is testing Abatacept & Teplizumab 
- For individuals at stage 1 or 2
- Prevent the autoimmune responses that result in progression to type 1 diabetes diagnosis (stage 3)